Targeting Fibrosis: ALA ‐ PDT Triggers PINK1 /Parkin‐Dependent Mitophagy and Apoptosis in Fibroblasts

This is the authors' abstract. We don't add key points for this paper.

Fibroblasts are key contributors to fibrosis due to their hyperproliferative and apoptosis-resistant phenotype. This study explores how 5-aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) induces apoptosis in fibroblasts by modulating mitochondrial quality control. ALA-PDT significantly reduces cell viability and proliferation, increases LDH release, and triggers apoptotic signaling. Mechanistically, ALA-PDT promotes excessive accumulation of mitochondrial and cytosolic reactive oxygen species (ROS), leading to mitochondrial dysfunction and energy stress. These alterations activate the AMPK/mTOR signaling cascade, which in turn upregulates PINK1/Parkin-mediated mitophagy. Suppression of mitophagy through siRNA targeting PINK1 or Parkin, or with pharmacological autophagy inhibitors, markedly attenuates ALA-PDT-induced apoptosis, confirming the pivotal role of mitophagy in this process. Transmission electron microscopy shows abundant autophagosome formation, while Western blotting validates the amount of mitophagy-related and apoptotic proteins. These findings establish a mechanistic link between ALA-PDT-induced oxidative stress and mitophagy-dependent apoptosis, identifying a novel anti-fibrotic pathway involving ROS-AMPK/mTOR-PINK1/Parkin signaling. The results offer a compelling molecular basis for using ALA-PDT as a targeted therapeutic strategy against fibrotic diseases by promoting the selective elimination of activated fibroblasts.